Renier Brentjens, MD, PhD, and Marco Davila, MD, PhD, will host a satellite symposium during this year’s ASH meeting to discuss the evolving landscape of CAR T-cell therapy.
“Bridging the Gaps in Cell Therapy for Hematologic Malignancies: Expert Guidance, Clinical Experience and Increased Access” will cover critical unmet needs in the field, including:
- Optimizing CAR T cells in real-world practice
- Sequencing therapies
- Managing post-relapse scenarios
- Understanding resistance biology
- Expanding access to underserved populations.
Don’t miss out – Register today!